| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |